GoodRx Releases List of 30 Heart Medications Under $30
The cheapest medication on the list is hydrochlorothiazide at $4.55.
heart pills © bmarya83 - stock.adobe.com
The prescription cost-saving service GoodRx released today a list of 30 of the most common heart drugs that will be available to customers for under $30. The coupon codes will work at more than 70,000 pharmacies nationwide.
Cardiovascular disease currently affects almost half of Americans.
Some of the drugs available at the new rates are lisinopril, an ACE inhibitor, for $9.29; carvedilol, a beta blocker, for $10.68; and atorvastatin, a statin, for $10.10.
GoodRx has directly contributed to the prevention of at least 140,000 emergency room visits, according to their recent report, The GoodRx Effect.
“Improving access to affordable medications is the most important thing we can do to improve Americans’ heart health. The second most important is ensuring access to helpful, accurate information,” said Karla Robinson, MD, Medical Editor at GoodRx in a press release.
Optimize Your Healthcare Payments with Optum Financial
April 29th 2025Discover how Optum Financial is revolutionizing healthcare payments in our latest whitepaper. Learn how transitioning to electronic payments can reduce administrative costs, streamline claims processing and enhance security.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Healthcare hasn't been a priority of the second Trump administration so far, panelists at the Asembia agreed. Medicaid may loom large, though, as the administration and congressional Republicans look for ways to slash government spending as a way of offsetting major tax cuts.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
What 5 Managed Care Trends Experts Say You’re Not Watching Closely Enough
April 29th 2025Managed Healthcare Executive asked several experts in healthcare and managed care two share the trends they think the industry is overlooking. From rising costs and data challenges to shifts in how care is delivered, these are the issues that could have a major impact — and deserve a closer look.
Read More
